The Latest Cardiac and Vascular News
Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options WESTMINSTER, Colo., May 02, 2022 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported first […]
PARIS–(BUSINESS WIRE)–Cardiawave SA, a deeptech medical device manufacturer that has developed VALVOSOFT® a revolutionary non-invasive medical device to treat aortic stenosis, the most prevalent heart valve disease in adults, today announced the authorization by the French National Agency for the Safety of Medicines and Health Products to proceed with a […]
First-Quarter 2022 Revenues of $25.7 Billion, Reflecting 82% Operational Growth; Excluding Contributions from Comirnaty(1) and Paxlovid, Revenues Increased 2% Operationally First-Quarter 2022 Reported Diluted EPS(2) of $1.37 and Adjusted Diluted EPS(3) of $1.62 Both Reported(2) and Adjusted(3) Diluted EPS Include a $0.05 Negative Impact for Acquired In-Process R&D Expenses(4), Which Prior to First-Quarter 2022 Had […]
Integrated patch offers ECG, heart rate, respiratory rate, and blood pressure monitoring for commercial research and development Campbell, Calif. – May 3, 2022 – Vivalink, a leading provider of digital healthcare solutions, announces availability of the world’s first multi-vital blood pressure patch for remote patient monitoring for use in commercial […]
American Heart Association consortium advances development of evidence-based health tech solutions PLEASANTON, Calif., May 3, 2022 /PRNewswire/ — Movano, a healthcare solutions company at the intersection of medtech and consumer devices, has joined the American Heart Association Center for Health Technology & Innovation’s (the Center) Innovators’ Network. The Center is focused on building […]
SUNNYVALE, Calif., May 02, 2022 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that that the U.S. Food and Drug Administration (FDA) approved expanded indications for the ENROUTE stent to include patients at standard […]
EXPAND TAVR II Pivotal Trial evaluating the Evolut™ TAVR platform in a new patient population Medtronic today announced the first patient enrollment in the EXPAND TAVR II Pivotal Trial, the first randomized clinical trial evaluating the self-expanding, supra-annular Evolut™ TAVR platform in patients with moderate, symptomatic aortic stenosis (AS), a […]
Announcement Follows FDA 510(k) Clearance of Device REHOVOT, Israel, April 29, 2022 /PRNewswire/ — Today, Xcardia Innovation Ltd., a private medical device company developing innovative cardiac pacemaker and defibrillator technology, announced the first-in-human use of its new Xtractor device in patients undergoing lead extraction procedures. Charles J. Love MD, Director, Cardiac Rhythm Device Services and […]
MONMOUTH JUNCTION, N.J., May 2, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announced that the Company has been awarded a new preferred supplier agreement for CytoSorb® with the Asklepios Group (Asklepios), one of the largest private […]
– Patients successfully self-managed PSVT episodes with etripamil which reduced need for ED intervention – – As in other studies, etripamil was well tolerated by patients – – Data to be featured during late breaking session at Heart Rhythm 2022 – MONTREAL and CHARLOTTE, N.C., April 30, 2022 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), […]
